Trials / Sponsors / Bioeq GmbH
Bioeq GmbH
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Double-blind Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinuma Plaque Psoriasis | Phase 3 | 2020-11-09 |
| Completed | Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Neovascular Age-related Macular Degeneration | Phase 3 | 2020-07-21 |
| Completed | Efficacy and Safety of the Biosimilar Ranibizumab FYB201 in Comparison to Lucentis in Patients With Neovascula Age-related Macular Degeneration (AMD) | Phase 3 | 2015-12-19 |